Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
09/1992
09/22/1992CA1307788C 1,2,3,3a,8,8a-hexahydro-3a,8(and 1,3a,8)-di(and tri)methylpyrrolo¬2,3-b|indoles, a process for their preparation and their use as medicaments
09/22/1992CA1307787C Substituted aminoalkanoylaminoalkyl phosphonate angiotensin converting enzyme inhibitors
09/22/1992CA1307741C Use of alpha-21 selective adrenergic receptor agonists in memory enhancement
09/22/1992CA1307739C Anti-inflammatory compositions
09/20/1992CA2063369A1 Selective phenylation of 5-hydroxy-beta-carboline derivatives
09/17/1992WO1992015592A1 TETRAHYDROTHIENO(2,3-c)PYRIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL APPLICATION
09/17/1992WO1992015565A1 Nmda antagonists
09/17/1992WO1992015551A1 Aliphatic propargylamines as selective mao-b inhibitors and as neuroprotective agents
09/17/1992WO1992015306A1 Use of nicotinic analogs for treatment of degenerative diseases of the nervous system
09/17/1992WO1992015292A1 Therapeutic compositions to protect and resuscitate mammalian cells and methods for preparing and using same
09/17/1992DE4108527A1 Neue 1-(4-cyano-4-aryl-cyclohexyl)piperazine, ihre herstellung und verwendung New 1- (4-cyano-4-aryl-cyclohexyl) piperazine, their preparation and use
09/17/1992DE4108393A1 Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln New bi- and tricyclic ester amino alcohols, their production and their use in medicinal products
09/17/1992CA2362719A1 Synthesis of nicotinic analogs useful for the treatment of degenerative diseases of the nervous system
09/17/1992CA2105171A1 Aliphatic propargylamines as selective mao-b inhibitors and as neuroprotective agents
09/16/1992WO1992016528A1 New bi- and tricyclic aminoalcohol esters, their preparation and their use in medicaments
09/16/1992WO1992016516A1 New 1-aryl-4-piperazinyl-cyclohexanecarboxylic acid nitriles, their production and their use
09/16/1992EP0503844A1 Thienopyridine derivatives and pharmaceutical compositions containing them
09/16/1992EP0503563A2 Novel 8-substituted purines as selective adenosine receptor agents
09/16/1992EP0503440A1 Compositions containing sumatriptan
09/16/1992EP0503349A1 Hydrazone derivatives, their preparation and use
09/16/1992EP0503297A1 GLIA activating factor and its production
09/16/1992EP0503044A1 Peptide compounds of laevorotatory amino acids and ring molecules, and therapeutical applications thereof.
09/16/1992CN1064485A Imidazole, triazole and tetrazole derivatives
09/16/1992CA2099870A1 1-aryl-4-piperazinylcyclohexanecarbonitriles, the preparation and use thereof
09/16/1992CA2062853A1 Hydrazone derivatives, their preparation and use
09/15/1992US5147881 4-(1,2-benzisoxazolyl)piperidine antipsychotic agents
09/15/1992US5147878 Hypotensive, antiarrhythmia agents
09/15/1992CA1307537C N-naphthoylglycines as aldose reductase inhibitors
09/15/1992CA1307532C Azachromane derivates
09/15/1992CA1307526C Bcd tricyclic ergoline part-structure analogues
09/09/1992WO1992015295A1 Compositions containing sumatriptan
09/09/1992EP0502786A1 Process for the preparation of aryl(or heteroaryl)-piperazin-1-butyl-azole derivatives
09/09/1992EP0502502A1 Topical composition containing ketoprofen lysinate
09/09/1992EP0502314A1 Benzimidazol, medicaments containing them and process for their preparation
09/09/1992EP0502117A1 Polymers with alkyl- or heteroalkyl-aryl backbone and pharmaceutical compositions incorporating same
09/09/1992EP0502110A1 (hetero) 4-arylmethoxy phenyl diazole derivatives, method for preparing same, and their therapeutical applications.
09/09/1992EP0502015A1 N-acyl-substituted azacyclic compounds, processes for their preparation, and their use as pharmaceuticals
09/09/1992CN1064273A Benzene derivatives having ngf production-promoting activity
09/08/1992WO1992015591A1 Tetracyclic imidazoquinazoline derivatives, process for their preparation and pharmaceutical compositions containing them
09/08/1992WO1992015590A1 New meso-azacyclic aromatic acid amides and esters as novel serotonergic agents
09/08/1992US5145870 Aryloxyphenylpropylamines their preparation and use
09/08/1992US5145866 Method of treating anxiety with the aid of r(+)-3-amino-1-hydroxy-pyrrolidin-2-one
09/08/1992CA2105675A1 Heterocyclic compounds and their preparation and use
09/08/1992CA2082415A1 Meso-azacyclic aromatic acid amides and esters as novel serotonergic agents
09/08/1992CA2062468A1 Process for the preparation of aryl (or heteroaryl) piperazinylbutylazole derivatives
09/07/1992WO1992015681A1 HUMAN GALANIN, cDNA CLONES ENCODING HUMAN GALANIN AND A METHOD OF PRODUCING HUMAN GALANIN
09/07/1992CA2105572A1 Human galanin, cdna clones encoding human galanin and a method of producing human galanin
09/05/1992WO1992015332A1 Novel salts/ion pairs of non-steroidal anti-inflammatory drugs in various dosage forms
09/05/1992CA2104684A1 Salts/ion pairs of non-steroidal anti-inflammatory drugs in various dosage forms
09/03/1992WO1992014813A1 Neuroprotectant agents
09/03/1992WO1992014731A1 4-[(2-BENZOTHIAZOLYL)METHYLAMINO]-α-[(3,4-DIFLUOROPHENOXY)METHYL]-1-PIPERIDINEETHANOL
09/03/1992WO1992014710A1 Novel ureas and thioureas, preparation thereof and application in therapy
09/03/1992WO1992014697A1 Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers
09/03/1992WO1992014456A1 Use of pharmaceutical compounds in the treatment of symptoms of disorders related to neurological diseases and etiologically related symptomology
09/03/1992WO1992014453A1 Compositions and methods of treatment of sympathetically maintained pain
09/03/1992WO1992011850A3 Use of calpain inhibitors in the inhibition and treatment of neurodegeneration
09/03/1992CA2101933A1 Neuroprotectant agents
09/02/1992WO1992015585A1 1-azabicyclo[3.2.2]nonan-3-amine derivatives
09/02/1992WO1992015303A1 Treatment of cognitive disorders
09/02/1992WO1992015302A1 Treatment of addiction to drugs and substances of abuse
09/02/1992EP0501713A1 Optically active aminoketone derivative and method for preparing same
09/02/1992EP0501656A2 New benzene derivatives having (NGF) production-promoting activity
09/02/1992EP0501579A1 Naphthalene lactones as inhibitors of leukotriene biosynthesis
09/02/1992EP0501568A1 Substituted cyclic sulphamide derivatives
09/02/1992EP0501552A1 4-[(2-Benzothiazolyl)methylamino]-alpha-[(3,4-difluorophenoxy)methyl]-1-piperidineethanol
09/02/1992EP0501445A1 Pharmaceutical composition comprising interleukin-2
09/02/1992EP0501442A1 8-chloro-benzothiazepine-compound for prophylaxis and treatment of sequelae of cerebral neurocyte necrosis
09/02/1992EP0501378A1 NMDA Antagonists
09/02/1992EP0501251A2 The enantiomer (+)-N-(2-ethoxyphenyl)-N',N'-(1,2,2-trimethylpropyl)-2-nitroethen-1,1-diamine, method for its preparation and its use
09/02/1992EP0500864A1 Antimuscarinic bronchodilators
09/02/1992EP0500658A1 A nicotine containing stimulant unit.
09/02/1992CN1064075A Carbamic acid derivatives and method for preparing same
09/01/1992US5143936 Benzopyran compound and its pharmaceutical use
09/01/1992US5143924 Hypotensive agents
09/01/1992US5143923 Psychological disorders
09/01/1992US5143916 Naphthylpiperazines useful as 5-ht1a receptor ligands
09/01/1992US5143912 Muscle relaxants, anticonvulsants, anxiolytic agents
09/01/1992US5143829 One of the alanine residues following N-terminal methionine is removed
09/01/1992CA1307003C Phenyl carbamate
09/01/1992CA1306995C Cyclic amine and pharmacological composition
09/01/1992CA1306944C Lithium salt-containing pharmaceutical compositions
08/1992
08/29/1992CA2061716A1 Pyranylphenyl naphthalene lactones as inhibitors of leukotriene biosynthesis
08/28/1992WO1992015580A1 NEUROLEPTIC PERHYDRO-1H-PYRIDO[1,2-a]PYRAZINES
08/28/1992WO1992015561A2 Process for preparing trans-piperidine-2,5-dicarboxylates
08/28/1992CA2061918A1 Pharmaceutical compositions comprising a lymphokine
08/28/1992CA2061812A1 Substituted cyclic sulphamide derivatives
08/27/1992CA2061785A1 Optically active aminoketone derivative and method for preparing
08/27/1992CA2061353A1 Prophylactic and curing agent for sequelae of cerebral neurocyte dyscrasia
08/26/1992WO1992014364A1 Opiate receptor antagonist modulates hyperkinetic movement disorder
08/26/1992EP0500443A1 Phenylethanolamino- and phenylethanolaminomethyltetralines, process for their preparation, intermediates of this process and pharmaceutical compositions containing them
08/26/1992EP0500297A1 Substituted pyridinones and pyrimidinones as angiotensin II antagonists
08/26/1992EP0499995A2 Piperidine derivatives
08/26/1992EP0499983A1 Nootropic drug
08/26/1992EP0499755A1 Phenylethanolaminotetralines, process for their preparation, intermediates of this process and pharmaceutical compositions containing them
08/26/1992EP0499662A1 Compositions with enhanced penetration
08/26/1992CN1063870A Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes and 3-aminochromanes
08/26/1992CN1063869A Nitrogenous bicyclic derivatives, their preparation process, intermediates obtained, their use as medicaments and pharomaceutical composition containing them
08/26/1992CN1017992B Process for preparing piperidine opioid antagonists
08/26/1992CA2104000A1 4-[(2-benzothiazolyl)methylamino] -.alpha.-[(3,4-difluorophenoxy)methyl]-1-piperidineethanol
08/25/1992US5141962 N-pentyl-n-phenethyl-3-hydroxyphenethylamine as antagonist for opiate receptor